MIRA Pharmaceuticals, Inc.

MIRA

Healthcare Drug Manufacturers General

EPS
+66.7%
Free cash flow
−50.8%

Quarter to June 2026, against a year earlier

0.57 0.03 +5.56%
Market cap
$22.7M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
Net debt / EBITDA
1.1×
Dividend safety
n/a

MIRA Pharmaceuticals, Inc. (MIRA) Return on invested capital

Alert me on Return on invested capital

MIRA Pharmaceuticals, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −12,016.1%, down 12016.1 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from 0.00% (fiscal 2025) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is below the Drug Manufacturers General industry median of 6.26% and below the Healthcare sector median of 0.00%.

Return on invested capital, annual

Embed this chart

Annual newest first

Period Return on invested capital Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 0.00
FY2020 0.00% —

Against its own ten years

Low 0.00% High 0.00%
Ten-year median 0.00%
Current reading's percentile 100

Return on invested capital against peers

Company Return on invested capital
GSK GSK PLC Sponsored ADR compare 9.61%
OGN Organon & Co. compare 6.26%
GRFS Grifols, S.A. compare 4.76%
BIIB Biogen Inc. compare 1.94%
NSRX Nasus Pharma Ltd. compare 0.00%
SCLX Scilex Holding Company compare 0.00%
AMRN Amarin Corporation PLC compare −16.6%
MDCX Medicus Pharma Ltd compare −2,497.5%
MIRA MIRA Pharmaceuticals, Inc. −12,016.1%
Drug Manufacturers General industry median 6.26%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on MIRA